Seegene Inc - Company Profile

Powered by

All the data and insights you need on Seegene Inc in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Seegene Inc Strategy Report

  • Understand Seegene Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Seegene Inc: Overview

Select Item

Related keylists

Seegene Inc (Seegene) is a medical device company that develops molecular diagnostic reagents. The company offering products includes Seeplex, anyplex and magicplex among others in the areas of Respiratory Infections, Gastrointestinal Tract Infections, Sexually Transmitted Infections, Human Papillomavirus Infections, Tuberculosis, Sepsis and Meningitis, among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enable to detect multiple pathogens in single reactions using Real-time PCR methods. Seegene’s IVD reagents are used in testing respiratory pathogens, gastrointestinal pathogens, sexually transmitted infections, human papillomavirus, tuberculosis and sepsis and meningitis pathogen, among others. The company serves commercial laboratories, DNA chip-based companies and molecular diagnostic companies. It operates in the US, Canada, South Korea, Brazil, Mexico, Italy, Middle East, and Germany. Seegene is headquartered in Seoul, South Korea.

 Gain a 360-degree view of Seegene Inc and make more informed decisions for your business Gain a 360-degree view of Seegene Inc and make more informed decisions for your business Find out more
Headquarters South Korea
Address Taewon Bldg., 91, Ogeum-Ro, Songpa-Gu, Seoul, 05548
Website www.seegene.com
Telephone 82 2 22404000
No of Employees 215
Industry Medical Equipment
Ticker Symbol & Exchange 096530 (KDQ)
Revenue (2022) $281.4M -57% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -99.6% (2022 vs 2021)
Market Cap* $854.4M
Net Profit Margin (2022) XYZ -99.2% (2022 vs 2021)
* As of and is in US$
View Seegene Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Seegene Inc premium industry data and analytics

80+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

20+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Seegene Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Assays: Allplex
Allplex 2019-nCoV assay Anyplex
Allplex Bacterial Vaginosis Assay DPO
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Seegene Inc portfolio and identify potential areas for collaboration Understand Seegene Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Acquisitions/Mergers/Takeovers In January, the company announced the acquisition of 100% of the shares of Brex, a software planning and UX/UI company.
2024 Contracts/Agreements In January, the company entered into a partnership with Microsoft to drive the advancement of its SG OneSystem business.
2023 Contracts/Agreements In December, Seegene USA and Microbix Biosystems announced a collaboration under which Seegene USA will start offering Microbix’s QAPs products.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Seegene Inc Samil Pharmaceutical Co Ltd Hyundai Bioland Co Ltd Curexo Inc Seoul Pharma Co Ltd
Headquarters South Korea South Korea South Korea South Korea South Korea
City Seoul Seoul Cheongju Seoul Cheongju
State/Province Seoul - - - -
No. of Employees 215 395 258 92 176
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Jinsoo Choi Chief Executive Officer; Director Executive Board - 71
Cheon Jong Yoon Director; Chief Executive Officer Executive Board - 66
Chun Kyung Jun Director Non Executive Board - 76
Hyeoncheol Jeong Director Non Executive Board 2022 58
Ahn Myung Wook Director Non Executive Board 2023 63
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Seegene Inc key executives to enhance your sales strategy Gain insight into Seegene Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward